MIT Researchers Develop Nanoparticles for Personalized Cancer Vaccines

Researchers at MIT have developed nanoscale particles designed to deliver customized cancer antigens. This innovation aims to elicit a robust immune response against tumors, potentially allowing for personalized prevention or treatment strategies for individual cancer patients. The technology's adaptability to various antigens marks a significant step in targeted immunotherapy.